New England Journal of Medicine

Treatments show promise in metastatic melanoma

(HealthDay)—In metastatic melanoma, nivolumab improves overall and progression-free survival versus dacarbazine, and dabrafenib plus trametinib improves survival versus vemurafenib monotherapy, according ...

Nov 18, 2014
popularity 3.5 / 5 (2) | comments 0

New treatment for Marfan syndrome shows promise

An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new research shows. The findings ...

Nov 18, 2014
popularity 2.5 / 5 (2) | comments 0

Picture emerges of how kids get head injuries

A study in which more than 43,000 children were evaluated for head trauma offers an unprecedented picture of how children most frequently suffer head injuries, report physicians at Washington University School ...

Nov 12, 2014
popularity 5 / 5 (1) | comments 0

The Affordable Care Act in Kentucky, one year later

One year ago, Michael Stillman, M.D., and his colleague, Monalisa Tailor, M.D., both physicians with the University of Louisville Department of Medicine, wrote a New England Journal of Medicine "Perspective" article about ...

Nov 19, 2014
popularity 1 / 5 (1) | comments 1